scholarly journals INCIDENCE, RISK FACTORS & PATIENT OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING LIVING DONOR LIVER TRANSPLANT- A PROSPECTIVE SINGLE CENTRE STUDY

2020 ◽  
Vol 104 (S3) ◽  
pp. S344-S345
Author(s):  
Abhyudaysingh Rana ◽  
Arvinder Singh Soin ◽  
Amit Kumar Mahapatra ◽  
Ashwini Gadde ◽  
Neeraj Saraf ◽  
...  
2020 ◽  
Vol 35 (Supplement_3) ◽  
Author(s):  
Abhyudaysingh Rana ◽  
Ashwini Gadde ◽  
Amit Mahapatra ◽  
Neeraj Saraf ◽  
Arvinder Soin ◽  
...  

Abstract Background and Aims AKI is a major concern in the management of candidates for liver transplantation. Post-LT AKI is associated with worse short- and long-term recipient and graft outcomes and the subsequent development of chronic kidney disease (CKD ).Most of the studies done on this are on deceased donor Liver transplant ,or if done on Living donor are retrospective in nature & there is inconsistency in studies regarding definition of AKI To assess incidence, risk factor and outcomes of patient developing acute kidney injury(AKI) in patients undergoing living donor liver transplant(LT). Method This is a single center prospective study. Patients over age of 18 years undergoing living donor liver transplant were selected consecutively from Jan 19 to April 19, prospectively followed for 1 month post op to assess incidence of AKI(Early-<=7,Late >7 to <30) & reassessed at 3 months for persistence of renal dysfunction .Patients with fulminant liver failure, those undergoing combined liver kidney transplant & who died within first 72 hour post-LT were excluded .AKI was defined by KDIGO criteria. Preoperative, Intraoperative & Post operative variables were analysed for risk factor & patient outcomes by regression analysis. Results 62 patients underwent LDLT between period of Jan 2019 to April 2019 .22(35%) patients developed AKI .15 (68%) had stage 1 AKI ,5 (23%) Stage 2 & 2(9%) had stage 3 AKI requiring CRRT.14 (64 %) patients had early AKI ,8 (36%) had late AKI.Acute CNI toxicity (3,14%) was most common cause of early AKI.Most common cause of Late AKI was Sepsis (7,11%).Use of vasopressors intra op & Past history of AKI (HRS) were the only statistically significant(p <0.001) risk factors for AKI .The mean ICU stay among patients with AKI was 7.2 ±4.2 days vs 4.5±1.2 days in patients without AKI .Median days to normalization of liver enzymes in non AKI group was 10 days vs 20 days in AKI group.2 (3.2%)patient had persistence of renal dysfunction at 3 month. 7(11.2%) patients died during analysis period, 2(3%) of them from AKI group. Conclusion - Incidence of AKI (35%) was higher in our study as compared to other cohort but lead to CKD in 2 patients . Past history of AKI (HRS) was a significant risk factor for Post op AKI though pre transplant e GFR did not differ in both group. Although AKI was transient but it lead to increase ventilator stay ,ICU stay and prolonged normalization of graft function in patients undergoing Living donor liver transplant.


2019 ◽  
Vol 51 (5) ◽  
pp. 1516-1519
Author(s):  
Koki Sato ◽  
Masahiro Ohira ◽  
Seiichi Shimizu ◽  
Yuki Imaoka ◽  
Shinji Hashimoto ◽  
...  

2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S132-S132
Author(s):  
Si-Ho Kim ◽  
Seokjun Mun ◽  
Hyunjoo Lee ◽  
Eliel Nam ◽  
Kyungmin Huh ◽  
...  

Abstract Background Bloodstream infections (BSIs) represent a poor prognosis in living-donor liver transplant recipients (LDLT-Rs). Some patients develop recurrent BSIs. We evaluated the impacts of ER-BSIs on outcomes in LDLT-Rs. Methods All LDLT-Rs with follow-up data between January 2008 and December 2016 were included. Early BSIs (E-BSIs) defined as BSI events within 2 months after LDLT. ER-BSI was defined as new-onset BSI within 2 months due to another pathogen ≥48-hour interval, or relapse of BSI by the same pathogen ≥1-week interval with negative cultures in between. Logistic regression model was used to analyze risk factors for 1-year mortality. An associated factor of E-BSI and ER-BSI were also evaluated. Results Among 727 LDLT-Rs, 108 patients had 149 events with 170 isolated pathogens of E-BSI. Twenty-eight patients (25.9%, 28/108) experienced ER-BSI. Enterococcus (37.6%) was the most common pathogen. Intra-abdominal infection was the most common focus in the first episode of E-BSI and even significantly more common in ≥ second (59.3% vs. 82.9%, P = 0.007). Intra-abdominal and/or biliary complications were risk factors for both E-BSI and ER-BSI. Whereas high MELD score, longer cold ischemic time and longer recipient operative time were associated with E-BSI, longer post-transplant intensive care unit stay and longer donor operative time was associated with ER-BSI. 1-year survival rates of patients with or without single event of E-BSI were 81.3% and 92.4%, respectively. Patients having ER-BSI showed significantly low 1-year survival rates of 28.6% (Figure 1). ER-BSI was the most relevant risk factor for 1-year mortality (adjusted OR = 8.26; 95% CI = 4.30–15.88). Conclusion LDLT-Rs with ER-BSI showed very low survival rates accompanying with intra-abdominal and/or biliary complications. Clinicians should aware to prevent recurrence of BSI focusing on intra-abdominal complications in order to improve clinical outcomes of LDLT-R. Disclosures All authors: No reported disclosures.


2007 ◽  
Vol 13 (4) ◽  
pp. 566-570 ◽  
Author(s):  
Makoto Osawa ◽  
Yutaka Ito ◽  
Toyohiro Hirai ◽  
Rie Isozumi ◽  
Shunji Takakura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document